Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial
Allurion Technologies (NYSE: ALUR) has appointed Adrian Wild as Senior Vice President, International Commercial, effective August 13, 2024. Mr. Wild brings over 20 years of experience in building profitable commercial organizations at leading healthcare brands. He will lead Allurion's international commercial sales and operations functions as the company aims to advance toward profitability in the expanding obesity market.
Mr. Wild's extensive experience includes leadership roles at Align Technology, where he contributed to establishing a new standard of care and oversaw expansion in Europe. Most recently, he served as SVP and Head of Western Europe at Straumann Group, driving significant growth through strategic marketing and operational initiatives. Prior to that, he was VP, Commercial Excellence Global at Mölnlycke Health Care, improving commercial effectiveness across more than 100 countries.
Allurion Technologies (NYSE: ALUR) ha nominato Adrian Wild come Vicepresidente Senior, Commerciale Internazionale, a partire dal 13 agosto 2024. Il signor Wild porta con sé oltre 20 anni di esperienza nella creazione di organizzazioni commerciali profittevoli presso brand leader nel settore sanitario. Dirigerà le funzioni di vendite e operazioni commerciali internazionali di Allurion mentre l'azienda punta a progredire verso la redditività nel mercato in espansione dell'obesità.
La vasta esperienza del signor Wild include ruoli di leadership in Align Technology, dove ha contribuito a stabilire un nuovo standard di cura e ha supervisionato l'espansione in Europa. Più recentemente, ha ricoperto il ruolo di SVP e Responsabile dell'Europa occidentale presso Straumann Group, guidando una crescita significativa attraverso iniziative di marketing strategico e operazioni. Prima di questo, è stato VP, Eccellenza Commerciale Globale presso Mölnlycke Health Care, migliorando l'efficacia commerciale in oltre 100 paesi.
Allurion Technologies (NYSE: ALUR) ha nombrado a Adrian Wild como Vicepresidente Senior, Comercial Internacional, con efecto a partir del 13 de agosto de 2024. El Sr. Wild aporta más de 20 años de experiencia en la creación de organizaciones comerciales rentables en marcas líderes del sector salud. Dirigirá las funciones de ventas y operaciones comerciales internacionales de Allurion mientras la empresa busca avanzar hacia la rentabilidad en el creciente mercado de la obesidad.
La amplia experiencia del Sr. Wild incluye roles de liderazgo en Align Technology, donde contribuyó a establecer un nuevo estándar de atención y supervisó la expansión en Europa. Más recientemente, se desempeñó como SVP y Jefe de Europa Occidental en Straumann Group, impulsando un crecimiento significativo a través de iniciativas de marketing estratégico y operativas. Antes de eso, fue VP de Excelencia Comercial Global en Mölnlycke Health Care, mejorando la efectividad comercial en más de 100 países.
Allurion Technologies(NYSE: ALUR)가 Adrian Wild를 국제 상업 부문 수석 부사장으로 임명했습니다, 2024년 8월 13일부로 효력을 발생합니다. Wild 씨는 주요 의료 브랜드에서 수익성 있는 상업 조직을 구축한 20년 이상의 경험을 가지고 있습니다. 그는 Allurion의 국제 상업 판매 및 운영 기능을 이끌며 회사가 확장되는 비만 시장에서 수익성으로 나아가는 것을 목표로 하고 있습니다.
Wild 씨의 폭넓은 경험에는 Align Technology에서의 리더십 역할이 포함되어 있으며, 이곳에서 그는 새로운 치료 기준을 정립하고 유럽에서의 확장을 감독했습니다. 최근에는 Straumann Group의 서유럽 본부장 및 SVP로 재직하며 전략적 마케팅 및 운영 이니셔티브를 통해 상당한 성장을 이끌었습니다. 그 전에는 Mölnlycke Health Care의 글로벌 상업 우수성 VP로서 100개 이상의 국가에서 상업적 효과를 개선했습니다.
Allurion Technologies (NYSE: ALUR) a nommé Adrian Wild au poste de Vice-Président Senior, Commercial International, à compter du 13 août 2024. M. Wild apporte plus de 20 ans d'expérience dans la création d'organisations commerciales rentables au sein de grandes marques de santé. Il dirigera les fonctions de vente et d'opérations commerciales internationales d'Allurion alors que l'entreprise vise à progresser vers la rentabilité sur le marché en expansion de l'obésité.
Une vaste expérience de M. Wild comprend des rôles de direction chez Align Technology, où il a contribué à établir une nouvelle norme de soins et a supervisé l'expansion en Europe. Plus récemment, il a été SVP et Responsable de l'Europe de l'Ouest chez Straumann Group, contribuant à une croissance significative grâce à des initiatives de marketing stratégique et d'opérations. Avant cela, il était VP, Excellence Commerciale Mondiale chez Mölnlycke Health Care, améliorant l'efficacité commerciale dans plus de 100 pays.
Allurion Technologies (NYSE: ALUR) hat Adrian Wild zum Senior Vice President, International Commercial ernannt, mit Wirkung zum 13. August 2024. Herr Wild bringt über 20 Jahre Erfahrung in der Schaffung profitabler Handelsorganisationen bei führenden Gesundheitsmarken mit. Er wird die internationalen Verkaufs- und Betriebsfunktionen von Allurion leiten, während das Unternehmen darauf abzielt, im wachsenden Markt für Fettleibigkeit rentabel zu werden.
Die umfangreiche Erfahrung von Herrn Wild umfasst Führungspositionen bei Align Technology, wo er zur Etablierung eines neuen Versorgungsstandards beigetragen und die Expansion in Europa überwacht hat. Zuletzt war er SVP und Leiter Westeuropa bei Straumann Group, wo er durch strategisches Marketing und betriebliche Initiativen ein erhebliches Wachstum vorantrieb. Davor war er VP, Commercial Excellence Global bei Mölnlycke Health Care, wo er die kommerzielle Effektivität in über 100 Ländern verbesserte.
- Appointment of experienced executive Adrian Wild as SVP, International Commercial
- Wild brings 20+ years of experience in building profitable commercial organizations
- Potential for improved international sales and operations under Wild's leadership
- Alignment with company's goal to advance toward profitability
- Opportunity to capitalize on expanding obesity market
- None.
Mr. Wild brings over 20 years of experience building profitable commercial organizations at leading healthcare brands
"We are thrilled to welcome Adrian to Allurion and add his expertise to our leadership team as we advance the company toward profitability," said Dr. Shantanu Gaur, Allurion’s Founder and CEO. "Adrian joins us at an extremely important time – where the obesity market is expanding by the day and presenting Allurion new opportunities for growth. Adrian’s expertise in building sustainable commercial organizations will be vital to our long-term success plans.”
“This is a great time to join Allurion as it enters a new stage of growth and development in an ever-expanding market,” said Mr. Wild. “I look forward to working with the talented team at Allurion to capitalize on this opportunity and take the company’s commercial organization to new heights.” Mr. Wild brings a wealth of experience in driving business growth and operational excellence across global markets. For over a decade, he held leadership roles at Align Technology where he contributed to establishing a new standard of care and oversaw Align’s expansion in
About Allurion
Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less™ intragastric balloon for weight loss, and offers access to the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Coach Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in
For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.
Allurion is a trademark of Allurion Technologies, Inc. in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240820207152/en/
Investors
Mike Cavanaugh, Investor Relations
ICR Westwicke
(617) 877-9641
mike.cavanaugh@westwicke.com
Global Media
Cedric Damour
PR Manager
+33 7 84 21 02 20
cdamour@allurion.com
Source: Allurion Technologies, Inc.
FAQ
When does Adrian Wild start his role at Allurion Technologies (ALUR)?
What is Adrian Wild's previous experience before joining Allurion (ALUR)?
What will be Adrian Wild's responsibilities at Allurion Technologies (ALUR)?
How does Allurion (ALUR) expect to benefit from Adrian Wild's appointment?
